Jane Street Group, LLC Oragenics Inc Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $14.18 $5,006 - $308,641	21,766 Added 61.09%	57,393 $13,000
Q2 2022 Aug 16, 2022	SELL	$0.24 - $0.42 $3,515 - $6,152	-14,649 Reduced 29.14%	35,627 $12,000
Q1 2022 May 17, 2022	BUY	$0.33 - $0.56 $5,309 - $9,010	16,090 Added 47.07%	50,276 $17,000
Q4 2021 Feb 15, 2022	SELL	$0.43 - $0.69 $9,244 - $14,834	-21,499 Reduced 38.61%	34,186 $15,000
Q3 2021 Nov 16, 2021	BUY	$0.58 - $0.84 $32,297 - $46,775	55,685 New	55,685 $35,000
Q2 2021 Aug 16, 2021	SELL	$0.6 - $0.89 $19,809 - $29,383	-33,015 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$0.52 - $1.52 $17,167 - $50,182	33,015 New	33,015 $30,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $40.7M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.